header logo image

Earnings Preview: Biotechnology Looks Healthy – Barron’s

April 10th, 2017 7:42 pm

Barron's
Earnings Preview: Biotechnology Looks Healthy
Barron's
The iShares Nasdaq Biotechnology (IBB) has climbed 0.34%. Meanwhile the SPDR S&P Biotech ETF (XBI) has declined 0.21%. IBB could be benefiting from having a wider swath of companies, in addition to the fact that the average market cap of its index ...

and more »

More:
Earnings Preview: Biotechnology Looks Healthy - Barron's

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick